Drug fusions and conjugates

Details for Australian Patent Application No. 2010227552 (hide)

Owner Glaxo Group Limited

Inventors Herring, Christopher; Holt, Lucy J.; Jespers, Laurent S.; Mayer, Sebastian; Pupecka, Malgorzata

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2010227552

PCT Pub. Number WO2010/108937

Priority 61/163,917 27.03.09 US

Filing date 24 March 2010

Wipo publication date 30 September 2010

International Classifications

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

Event Publications

3 November 2011 PCT application entered the National Phase

  PCT publication WO2010/108937 Priority application(s): WO2010/108937

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010227557-Fertilization modulation compounds and process for implementing them

2010227550-Gingiva former and method for producing a design of a gingiva former